“…Reductive ART may be particularly relevant in resource-limited settings, but there are scarce data and no supportive recommendations [16]. Interestingly, in a Spanish clinical setting where reductive strategies are being used, only nine of 92 patients (9.8%) had virologic rebound to above 50 copies/ml at 48 weeks after initiating darunavir/ ritonavir monotherapy [21,22]. Overall, the time is ripe for studies and expert opinion to harmonize approaches to ART reduction globally.…”